Biblio

[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is F  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
F
Futrega K, Yu J, Jones JW, Kane MA, Lott WB, Atkinson K, Doran MR. Polydimethylsiloxane (PDMS) modulates CD38 expression, absorbs retinoic acid and may perturb retinoid signalling. Lab Chip. 2016.
Futamura M, Ozaki Y, Makino H, Tsujimoto S, Shigesaka M, Tanaka A, Shimamoto K, Son Y, Ito T, Nomura S. A Case of Anti-MDA-5 Antibody-positive Dermatomyositis after Allogeneic Bone Marrow Transplantation for Acute Transformation of Chronic Myelogenous Leukemia. Intern Med. 2022.
Fussbroich D, Kohnle C, Schwenger T, Driessler C, Dücker RP, Eickmeier O, Gottwald G, Jerkic SP, Zielen S, Kreyenberg H, et al. A combination of LCPUFAs regulates the expression of miRNA-146a-5p in a murine asthma model and human alveolar cells. Prostaglandins Other Lipid Mediat. 2019:106378.
Fusco C, Cervelli C, Dal Mas A, Canossi A, Azzarone R, Valdez O, Auriemma L, Madalese D, Maisto G, Toriello M, et al. Expression profile of HLA-B*38:55Q allele. HLA. 2019.
Fusco P, Mattiuzzo E, Frasson C, Viola G, Cimetta E, Esposito MRosaria, Tonini GPaolo. Verteporfin induces apoptosis and reduces the stem cell-like properties in Neuroblastoma tumour-initiating cells through inhibition of the YAP/TAZ pathway. Eur J Pharmacol. 2020:173829.
Furuyama S, Wu QVicky, Varnum-Finney B, Sandstrom R, Meuleman W, Stamatoyannopoulos JA, Bernstein ID. Inaccessible LCG Promoters Act as Safeguards to Restrict T Cell Development to Appropriate Notch Signaling Environments. Stem Cell Reports. 2021.
Furuya Y, Mera H, Itokazu M, Terai S, Nakamura H, Wakitani S, Yasuda H. Induction of chondrogenesis with a RANKL-binding peptide, WP9QY, in vitro and in vivo in a rabbit model. Biochem Biophys Res Commun. 2022;602:98-104.
Furuta T, Oda T, Kiyoi K, Ozawa Y, Kimura S, Kurimori K, Miyazaki Y, Yu Y, Furuya K, Akashi Y, et al. Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells. Cancer Sci. 2021.
Furuta A, Kuroda Y, Yamamoto T, Egawa S, Dezawa M, Yoshimura N. Effects of human Muse cells on bladder inflammation, overactivity, and nociception in a chemically induced Hunner-type interstitial cystitis-like rat model. Int Urogynecol J. 2022.
Furuse Y, Finethy R, Saka HA, Xet-Mull AM, Sisk DM, Smith KLJurcic, Lee S, Coers J, Valdivia RH, Tobin DM, et al. Search for MicroRNAs Expressed by Intracellular Bacterial Pathogens in Infected Mammalian Cells. PLoS One. 2014;9(9):e106434.
Furundarena JRamón, Uranga A, Alkorta A, González C, Ferreiro JJavier, Rey M, Aragón L, Urreta I, Emparanza JIgnacio, Redín H, et al. Evaluation of the predictive value of the hematopoietic progenitor cell count using an automated hematology analyzer for CD34+ stem cell mobilization and apheresis product yield. Int J Lab Hematol. 2019.
Furukawa J-I, Okada K, Shinohara Y. Glycomics of human embryonic stem cells and human induced pluripotent stem cells. Glycoconj J. 2016.
Furukawa Y, Odashima A, Hoshino T, Onodera S, Saito A, Ichinohe T, Azuma T. Effects of KnockOut Serum Replacement on Differentiation of Mouse-Induced Pluripotent Stem Cells into Odontoblasts. Bull Tokyo Dent Coll. 2022.
Furtado MB, Wilmanns JC, Chandran A, Tonta M, Biben C, Eichenlaub M, Coleman HA, Berger S, Bouveret R, Singh R, et al. A novel conditional mouse model for Nkx2-5 reveals transcriptional regulation of cardiac ion channels. Differentiation. 2016.
Fürstenau M, Giza A, Stumpf T, Robrecht S, Maurer C, Linde H, Jacobasch L, Dörfel S, Aldaoud A, von Tresckow J, et al. Second primary malignancies in treated and untreated patients with chronic lymphocytic leukemia. Am J Hematol. 2021.
Furstenau D, Peer CJ, Hughes TE, Uchida N, Tisdale J, O Hall M, Figg WD, Hsieh M. Alemtuzumab Clearance, Lymphocyte Count, and T-Cell Chimerism After Hematopoietic Stem Cell Transplant in Sickle Cell Disease. Pharmacotherapy. 2021.
Fursova NA, Blackledge NP, Nakayama M, Ito S, Koseki Y, Farcas AM, King HW, Koseki H, Klose RJ. Synergy between Variant PRC1 Complexes Defines Polycomb-Mediated Gene Repression. Mol Cell. 2019.
Fürsatz M, Gerges P, Wolbank S, Nürnberger S. Autonomous spheroid formation by culture plate compartmentation. Biofabrication. 2021.
Furmston J, Patel A, Ludwinski F, Zuzel V, Bajwa A, Saha P, Smith A, Modarai B. Angiogenic cell therapy for critical limb ischaemia: an update on concepts and trials. J Cardiovasc Surg (Torino). 2014.
Furman WL, McCarville B, Shulkin BL, Davidoff A, Krasin M, Hsu C-W, Pan H, Wu J, Brennan R, Bishop MW, et al. Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A. J Clin Oncol. 2021:JCO2101375.
Furlan FLuiza Schu, Lemes MAndres, Suguimatsu LCecilia Fu, Pires CTeixeira F, Santos MLucia Schm. X-LINKED ADRENOLEUKODYSTROPHY IN BRAZIL: A CASE SERIES. Rev Paul Pediatr. 2019.
Furfaro E, Nicolini L, Vecchia ADella, Di Grazia C, Raiola AMaria, Varaldo R, Ferrando F, Barisione G, Bruzzone B, Angelucci E, et al. HEV infection in an Italian cohort of HSCT recipients: seroprevalence and infection. Biol Blood Marrow Transplant. 2020.
Füreder W, Cerny-Reiterer S, Sperr WR, Müllauer L, Jäger E, Schwarzinger I, Geissler K, Valent P. Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm. Wien Klin Wochenschr. 2016.
Füreder W, Paulitsch-Buckingham A, Rabitsch W, Jäger E, Schwarzinger I, Sperr WR, Valent P. Evaluation of treatment responses and colony-forming progenitor cells in 50 patients with aplastic anemia after immunosuppressive therapy or hematopoietic stem cell transplantation: a single-center experience. Wien Klin Wochenschr. 2014.
Fuoco T, Ahlinder A, Jain S, Mustafa K, Finne-Wistrand A. Poly(ε-caprolactone-co-p-dioxanone): a degradable and printable copolymer for pliable 3D scaffolds fabrication towards adipose tissue regeneration. Biomacromolecules. 2019.

Pages